Literature DB >> 27034430

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis.

Rajshekhar Chakraborty1, Anne J Novak2, Stephen M Ansell2, Eli Muchtar2, Prashant Kapoor2, Suzanne R Hayman2, Angela Dispenzieri2, Francis K Buadi2, Martha Q Lacy2, Rebecca L King3, Morie A Gertz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27034430     DOI： 10.1182/blood-2016-02-702035

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

Review 1.  MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.

Authors:  Miguel Alcoceba; María García-Álvarez; Alejandro Medina; Rebeca Maldonado; Verónica González-Calle; María Carmen Chillón; María Eugenia Sarasquete; Marcos González; Ramón García-Sanz; Cristina Jiménez
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

Review 2.  Waldenstrom's Macroglobulinemia: An Update.

Authors:  Maddalena Mazzucchelli; Anna Maria Frustaci; Marina Deodato; Roberto Cairoli; Alessandra Tedeschi
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

3.  Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia).

Authors:  Maroun Bou Zerdan; Jason Valent; Maria Julia Diacovo; Karl Theil; Chakra P Chaulagain
Journal:  Adv Hematol       Date:  2022-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.